Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
43.9M
-
Shares change
-
+532K
-
Total reported value, excl. options
-
$202M
-
Value change
-
+$2.28M
-
Put/Call ratio
-
13.02
-
Number of buys
-
62
-
Number of sells
-
-71
-
Price
-
$4.59
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q1 2025
171 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.9M shares
of 58.9M outstanding shares and own 74.61% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (9.13M shares), RENAISSANCE TECHNOLOGIES LLC (3.57M shares), VANGUARD GROUP INC (3.5M shares), DIMENSIONAL FUND ADVISORS LP (2.54M shares), TANG CAPITAL MANAGEMENT LLC (2.35M shares), MILLENNIUM MANAGEMENT LLC (2.14M shares), ACADIAN ASSET MANAGEMENT LLC (1.89M shares), GEODE CAPITAL MANAGEMENT, LLC (1.61M shares), STATE STREET CORP (1.25M shares), and Connor, Clark & Lunn Investment Management Ltd. (930K shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.